3. The following descriptions and classes of medicinal products are specified for the purposes of section 58, namely—
(a)medicinal products in respect of which a marketing authorization has been granted, which in the marketing authorization are classified as being prescription only medicines;
(b)medicinal products in respect of which no marketing authorization has been granted consisting of or containing a substance listed in column 1 of Schedule 1;
(c)medicinal products that are for parenteral administration;
(d)medicinal products that are controlled drugs unless a marketing authorization has been granted in respect of that medicinal product in which the product is classified as being a pharmacy only or on general sale list medicine;
(e)cyanogenetic substances, other than preparations for external use;
(f)medicinal products that on administration emit radiation, or contain or generate any substance which emits radiation, in order that radiation may be used.
[F2(g)medicinal products in respect of which a marketing authorization has been granted consisting of or containing aloxiprin, aspirin or paracetamol in the form of non-effervescent tablets or capsules which in the marketing authorization are classified as being pharmacy only or general sale list medicines.]
[F3(h)medicinal products in respect of which a marketing authorization has been granted consisting of or containing pseudoephedrine salts or ephedrine base or salts in all pharmaceutical forms which in the marketing authorization are classified as being pharmacy only medicines.]]
Textual Amendments
F1Art. 3 substituted (1.4.2002) by The Prescription Only Medicines (Human Use) Amendment Order 2002 (S.I. 2002/549), arts. 1(1), 4
F2Art. 3(g) added (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 4
F3Art. 3(h) inserted (1.4.2008) by The Prescription Only Medicines (Human Use) Amendment Order 2008 (S.I. 2008/464), arts. 1(1), 3